Global Hematological Malignancies Treatment Market to be Driven by Rapidly Growing Geriatric Population and Beneficial Government Initiatives During the Forecast Period 2021-2026

Expert Market Research’s new report titled ‘Global Hematological Malignancy Treatment Market Report and Forecast 2021-2026’, gives an in-depth analysis of the global Hematological Malignancy Treatment Market, assessing the market based on its segments such as applications, manufacturing process and major regions. The report tracks the latest industry trends and studies their impact on the overall market. It also assesses market dynamics, covering key demand and price indicators, as well as market analysis based on SWOT and Porter’s Five Forces models.

Get Free Sample Report With TOC:

Key highlights of the report include:

Market Overview (2016-2026)

  • Historical market size (2020): $52.1 billion
  • Forecast CAGR (2021-2026): 5%
  • Forecasted market size (2026): 94.8 billion USD

Globally, the rapidly growing geriatric population is expected to be a major driver of market growth throughout the forecast period owing to the rising incidence of hematological malignancies in the elderly. Advances in immunohistochemistry (IHC) have enabled the accurate diagnosis of hematological malignancies by exposing tissue samples to a variety of antibodies directed against cellular molecules and antigens. Increasing investment in the discovery of physiologically effective drugs, along with a favorable reimbursement landscape, is driving the growth of the market. Surgical therapy can be used to diagnose and treat lymphoma complications such as perforation, obstruction, or stenosis. This, in conjunction with the release of numerous new therapies and frequent label changes of high-priced drugs such as CAR T-cell therapies and brexucabtagene autoleuce, is propelling the growth of the market. Other significant market drivers include a growing awareness of the possibilities for early detection of certain diseases and an increase in the number of innovative drugs being approved for treatment. The market is expected to grow in the coming years with ongoing clinical trials aimed at developing new treatments for patients with advanced hematological malignancies.

Industry definition and major segments

Hematological malignancies are cancers of the blood, bone marrow and lymph nodes. This classification includes acute lymphoid leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), chronic myeloid leukemia (CML), myeloma and lymphoma (Hodgkin’s and non-(NHL)) . Hodgkin’s chemotherapy, radiotherapy, immunotherapy and stem cell transplantation are among the most widely recommended treatments for hematological malignancies.

Read Full Report with TOC:

By Type, the market is split into:

  • Leukemia
  • Lymphoma
  • Multiple myeloma
  • Others

By Industry, the market is split into:

  • Leukemia
  • Lymphoma
  • Multiple myeloma
  • Others

By region, the industry is classified into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Market trends

Chemotherapy now accounts for a major share of the hematological malignancies treatment market and is expected to grow at a steady rate during the forecast period. Chemotherapy is a type of cancer treatment that uses a mixture of drugs to stop the growth and spread of cancer cells. It is used to treat a number of different types of malignant blood tumours. Chemotherapy shrinks tumors and allows surgical resection of cancer in patients with only marginally resectable malignancies. The growing popularity of the segment is propelled by a large pool of patients and an increase in the incidence of blood cancers. Moreover, the growing awareness of the risk of the disease and its subsequent treatment is expected to boost the market growth.

North America is estimated to dominate the global hematological malignancies treatment market over the forecast period. North America accounts for a major share of the market owing to the presence of major players, high prevalence of blood cancer patients, developed healthcare infrastructure and availability of medicines of brand. Several factors are expected to drive the growth of the global market such as beneficial government initiatives and an increase in research collaborations among key market players.

Main market players

The major market players are Pfizer Inc., F. Hoffmann-LA Roche Ltd, Sanofi SA, Bristol-Myers Squibb Company, AbbVie Inc., Novartis AG, GlaxoSmithKline PLC, Amgen Inc., Johnson & Johnson, and Takeda Pharmaceutical Co. Ltd, among others. The report covers market shares, capacities, expansions, investments, and mergers and acquisitions, among other latest developments of these market players.

About Us:

Expert Market Research is a leading business intelligence firm, providing custom and syndicated market reports and advisory services to our clients. We serve a large clientele ranging from Fortune 1000 companies to small and medium-sized businesses. Our reports cover over 100 industries in established and emerging markets researched by our trained analysts who track the latest economic, demographic, business and market data globally.

At Expert Market Research, we tailor our approach based on the needs and preferences of our clients, providing them with valuable, actionable and up-to-date market insights, helping them realize their optimal growth potential. We offer market intelligence across a range of verticals including Pharmaceuticals, Food & Beverage, Technology, Retail, Chemicals & Materials, Energy & Mining, Packaging and farming.

Media Contact

Company name: EMR Inc.
Contact:-Ian Bell, Business Advisor
Email: [email protected]
Toll Free: USA +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
City: Sheridan
State: Wyoming
Country: United States

Read more reports:

Global N95 Respirator Market:

Global Vaccine Market:

Global Immunotherapy Drugs Market:

Global Anisole Market:

Global Antiviral Drugs Market:

Learn more about EMR Inc.’s Procurement Intelligence Services.

** At Expert Market Research, we always strive to give you the latest information. The figures in the article are only indicative and may differ from the actual report.

Source link

About Chris Y. Camp

Check Also

George Michael paid for stranger’s ‘miracle’ IVF treatment

George Michael paid for the IVF treatment of a stranger, we learned. The music icon …